The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers

B. M. Psaty, T. D. Koepsell, E. H. Wagner, J. P. LoGerfo and T. S. Inui
Department of Medicine, University of Washington, Seattle.

We conducted a population-based, case-control study of risk factors for first events of coronary heart disease in patients with high blood pressure. All subjects had hypertension treated with medication. The 248 cases presented with new coronary heart disease from 1982 through 1984, and the 737 controls were a probability sample of health maintenance organization patients free of coronary heart disease. The health maintenance organization's computerized pharmacy database identified recent stoppers--patients who did not fill their prescriptions regularly enough to be at least 80% compliant. After adjustment for potential confounding factors, subjects who had recently stopped using beta-blockers had a transient fourfold increase in the relative risk of coronary heart disease (relative risk, 4.5; 95% confidence interval, 1.1 to 18.5). The association was specific to beta-blockers but not diuretics. A withdrawal syndrome immediately following the cessation of beta-blocker use may be an acute precipitant of angina and myocardial infarction in hypertensive patients who have no prior history of coronary heart disease.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Influence of Beta-Blocker Continuation or Withdrawal on Outcomes in Patients Hospitalized With Heart Failure Findings From the OPTIMIZE-HF Program.
Fonarow et al.
J Am Coll Cardiol 2008;52:190-199.
ABSTRACT | FULL TEXT  

Perioperative beta-blockers in noncardiac surgery: Evolution of the evidence
HARTE and JAFFER
Cleveland Clinic Journal of Medicine 2008;75:513-519.
ABSTRACT | FULL TEXT  

Use of {beta} blockers in patients with COPD
Au
Thorax 2008;63:296-298.
FULL TEXT  

Use of {beta} blockers and the risk of death in hospitalised patients with acute exacerbations of COPD
Dransfield et al.
Thorax 2008;63:301-305.
ABSTRACT | FULL TEXT  

Quo Vadis, Perioperative Beta Blockade? Are You "POISE'd" on the Brink?
London
Anesth. Analg. 2008;106:1025-1030.
FULL TEXT  

Prevalence, Predictors, and Outcomes of Primary Nonadherence After Acute Myocardial Infarction
Jackevicius et al.
Circulation 2008;117:1028-1036.
ABSTRACT | FULL TEXT  

Predicting adherence to immunosuppressant therapy: a prospective analysis of the theory of planned behaviour
Chisholm et al.
Nephrol Dial Transplant 2007;22:2339-2348.
ABSTRACT | FULL TEXT  

Course of Depressive Symptoms and Medication Adherence After Acute Coronary Syndromes: An Electronic Medication Monitoring Study
Rieckmann et al.
J Am Coll Cardiol 2006;48:2218-2222.
ABSTRACT | FULL TEXT  

Recent Trials in Hypertension: Compelling Science or Commercial Speech?
Psaty et al.
JAMA 2006;295:1704-1706.
FULL TEXT  

{beta} blockers for elective surgery in elderly patients: population based, retrospective cohort study
Redelmeier et al.
BMJ 2005;331:932.
ABSTRACT | FULL TEXT  

Patient Adherence Improves Glycemic Control
Rhee et al.
The Diabetes Educator 2005;31:240-250.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of Adherence-Enhancing Interventions: A Quality Assessment of the Evidence
Elliott et al.
The Annals of Pharmacotherapy 2005;39:508-515.
ABSTRACT | FULL TEXT  

Expert consensus document on {beta}-adrenergic receptor blockers: The Task Force on Beta-Blockers of the European Society of Cardiology
Task Force Members et al.
Eur Heart J 2004;25:1341-1362.
FULL TEXT  

Periprocedural Hypertension: Current Concepts in Management for the Vascular Surgeon
Samson
VASC ENDOVASCULAR SURG 2004;38:361-366.
ABSTRACT  

Editorial II: Prevention of cardiac complications of non-cardiac surgery: stenosis and thrombosis
Newby and Nimmo
Br J Anaesth 2004;92:628-632.
FULL TEXT  

Drug Intolerance Due to Nonspecific Adverse Effects Related to Psychiatric Morbidity in Hypertensive Patients
Davies et al.
Arch Intern Med 2003;163:592-600.
ABSTRACT | FULL TEXT  

Effect of partial compliance on cardiovascular medication effectiveness
Cramer
Heart 2002;88:203-206.
FULL TEXT  

Association Between Inhaled {beta}-Agonists and the Risk of Unstable Angina and Myocardial Infarction
Au et al.
Chest 2002;121:846-851.
ABSTRACT | FULL TEXT  

Antihypertensive Drug Therapy in Saskatchewan: Patterns of Use and Determinants in Hypertension
Bourgault et al.
Arch Intern Med 2001;161:1873-1879.
ABSTRACT | FULL TEXT  

Discrepancies in the Use of Medications: Their Extent and Predictors in an Outpatient Practice
Bedell et al.
Arch Intern Med 2000;160:2129-2134.
ABSTRACT | FULL TEXT  

The Risk of Myocardial Infarction Associated with Inhaled beta -Adrenoceptor Agonists
AU et al.
Am. J. Respir. Crit. Care Med. 2000;161:827-830.
ABSTRACT | FULL TEXT  

An Increase in the Number of Deaths in the United States in the First Week of the Month
Rosenheck et al.
NEJM 1999;341:1548-1550.
FULL TEXT  

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)
Gibbons et al.
J Am Coll Cardiol 1999;33:2092-2197.
FULL TEXT  

North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management of stable angina
North of England Stable Angina Guideline Developme
BMJ 1996;312:827-832.
FULL TEXT  

Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population
Jones et al.
BMJ 1995;311:293-295.
ABSTRACT | FULL TEXT  

Safe Discontinuation of Antihypertensive Therapy
Kirk and Johnson
Arch Fam Med 1995;4:266-270.
ABSTRACT  

Adherence to Medication Regimens: Updating a Complex Medical Issue
O'Brien et al.
Med Care Res Rev 1992;49:435-454.
 

STOPPING BETA-BLOCKERS LEADS TO PERIOD OF HIGH RISK OF CORONARY EVENTS
JWatch General 1990;1990:4-4.
FULL TEXT